Simona Ferioli
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Simona Ferioli has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
- Brett M. Kissela
Department of Neurology and Rehabilitation Medicine, University of Cincinnati, OH
10 shared publications - Daniel Woo
Department of Neurology, University of Buffalo, NY; and
10 shared publications - Matthew L. Flaherty
Department of Neurology and Rehabilitation Medicine University of Cincinnati College of Medicine Cincinnati OH USA
10 shared publications - Charles J. Moomaw
Neurology, Univ of Cincinnati, Cincinnati, OH
9 shared publications - Kathleen Alwell
Univ of Cincinnati, Cincinnati, OH
7 shared publications - Opeolu Adeoye
Department of Emergency Medicine, Washington University in St. Louis, MO
7 shared publications
Latest Publications
- 22 January 2018
- Published by Wolters Kluwer Health in Stroke
- Vol. 49  (Suppl_1)
Abstract 82: Endovascular Therapy Eligibility in the Advent of DAWN and DEFUSE-3 Results
Introduction: We previously estimated that, among 2297 ischemic stroke patients in our 1.3 million metropolitan population in 2010, 159 were potentially IV rtPA (IVT)- and 29 were endovascular (EVT)-eligible based on AHA Class I, Level A guideline criteria; this projected to 31,000 IVT and 5600 EVT-eligible patients in the US annually. Given recent DAWN and DEFUSE 3 results suggesting EVT benefit beyond 6 hours to 24 hours, we aim to estimate the number of additional EVT-eligible patients in our region. Methods: We ascertained all hospitalized AIS patients ≥18 years old in 2010 using ICD-9 codes 430-436 within Greater Cincinnati/Northern Kentucky (GCNK) population; all cases were physician-reviewed. GCNK patients were considered potentially DAWN-eligible if ≥18 years, presenting within 5 to 23 hours from onset, and with a baseline NIHSS ≥10, prestroke mRS 0-1, platelets ≥50k, glucose 51-399 mg/dL, INR ≤3.0 and creatinine ≤3.0. Based on single-center (Pittsburgh) data, an eligibility proportion of 22% for both large vessel occlusion (LVO) and clinical-imaging-mismatch (CIM) was then applied. Additional patients eligible by only DEFUSE 3 criteria were identified within the GCNK population by including NIHSS 6-9, prestroke mRS 2, and an upper age of 90 years among patients presenting within 5 to 15 hours. Based on single-center (Bern) data, LVO rates by NIHSS score were applied. Based on DEFUSE 3 screening estimates, a 50% target mismatch (TTM) rate was then applied. Results: Among 2297 ischemic stroke patients hospitalized in our region, 34 were potentially DAWN-eligible, including 8 estimated to meet LVO and CIM criteria, and 19 additional patients were DEFUSE 3-eligible, including 4 estimated to meet LVO and TMM criteria. Conclusion: The 6-24 hour EVT treatment window may increase EVT eligibility by approximately 40% in the GCNK metropolitan region annually, although this estimate is limited by small sample sizes and inferences. Estimates will be updated as further data become available by the time of presentation of this
- 22 January 2018
- Published by Wolters Kluwer Health in Stroke
- Vol. 49  (Suppl_1)
Abstract 82: Endovascular Therapy Eligibility in the Advent of DAWN and DEFUSE-3 Results
Introduction: We previously estimated that, among 2297 ischemic stroke patients in our 1.3 million metropolitan population in 2010, 159 were potentially IV rtPA (IVT)- and 29 were endovascular (EVT)-eligible based on AHA Class I, Level A guideline criteria; this projected to 31,000 IVT and 5600 EVT-eligible patients in the US annually. Given recent DAWN and DEFUSE 3 results suggesting EVT benefit beyond 6 hours to 24 hours, we aim to estimate the number of additional EVT-eligible patients in our region. Methods: We ascertained all hospitalized AIS patients ≥18 years old in 2010 using ICD-9 codes 430-436 within Greater Cincinnati/Northern Kentucky (GCNK) population; all cases were physician-reviewed. GCNK patients were considered potentially DAWN-eligible if ≥18 years, presenting within 5 to 23 hours from onset, and with a baseline NIHSS ≥10, prestroke mRS 0-1, platelets ≥50k, glucose 51-399 mg/dL, INR ≤3.0 and creatinine ≤3.0. Based on single-center (Pittsburgh) data, an eligibility proportion of 22% for both large vessel occlusion (LVO) and clinical-imaging-mismatch (CIM) was then applied. Additional patients eligible by only DEFUSE 3 criteria were identified within the GCNK population by including NIHSS 6-9, prestroke mRS 2, and an upper age of 90 years among patients presenting within 5 to 15 hours. Based on single-center (Bern) data, LVO rates by NIHSS score were applied. Based on DEFUSE 3 screening estimates, a 50% target mismatch (TTM) rate was then applied. Results: Among 2297 ischemic stroke patients hospitalized in our region, 34 were potentially DAWN-eligible, including 8 estimated to meet LVO and CIM criteria, and 19 additional patients were DEFUSE 3-eligible, including 4 estimated to meet LVO and TMM criteria. Conclusion: The 6-24 hour EVT treatment window may increase EVT eligibility by approximately 40% in the GCNK metropolitan region annually, although this estimate is limited by small sample sizes and inferences. Estimates will be updated as further data become available by the time of presentation of this
- 22 January 2018
- Published by Wolters Kluwer Health in Stroke
- Vol. 49  (Suppl_1)
Abstract WP162: Outcomes and Long-Term Mortality After Ischemic Stroke in the Young: A Preliminary Analysis From the Greater Cincinnati/Northern Kentucky Stroke Study
Introduction: There is a trend towards ischemic stroke (IS) occurring at younger ages. We sought to better characterize outcomes and mortality over 3 years by age at time of stroke within a large, biracial population. Methods: Incident IS were ascertained during the 2005 and 2010 study periods of our population based epidemiology study via ICD-9 codes 430-436. Research nurse coordinators performed medical record abstraction on all potential events, which were then adjudicated by study physicians as case/not a case. Abstractions included discharge or 30-day outcomes (if available) as measured by modified Rankin scale (mRS). Mortality for IS events out to 3 years was determined via all available information including the Social Security Death Index. We compared the outcomes and post-stroke mortality by 20-55 (young stroke) versus >55 years, and by decade. Descriptive statistics are reported as n (%), and mean (SD) or median (25 th and 75 th %ile) as appropriate. The primary analysis examined the effect of age, race and sex using regression, life table and proportional hazards models. Results: Results are shown in the table. IS in the young occurred more frequently among black cases. The median rNIHSS was 3 although the NIHSS distribution trended towards more severe IS in the older age group. Young strokes had lower baseline and 30-day mRS. The mortality rate was greater in the older ages, at each time point and overall. After adjusting for race, sex and stroke severity the hazard ratio for lower survival in the strokes >55 years old was 4.03 (95% CI 3.15, 5.17). Conclusion: IS patients < 55 years old are less likely to die after stroke. Young stroke occurs in demographically different populations than older strokes and this group would benefit from further study.
- 22 January 2018
- Published by Wolters Kluwer Health in Stroke
- Vol. 49  (Suppl_1)
Abstract WP162: Outcomes and Long-Term Mortality After Ischemic Stroke in the Young: A Preliminary Analysis From the Greater Cincinnati/Northern Kentucky Stroke Study
Introduction: There is a trend towards ischemic stroke (IS) occurring at younger ages. We sought to better characterize outcomes and mortality over 3 years by age at time of stroke within a large, biracial population. Methods: Incident IS were ascertained during the 2005 and 2010 study periods of our population based epidemiology study via ICD-9 codes 430-436. Research nurse coordinators performed medical record abstraction on all potential events, which were then adjudicated by study physicians as case/not a case. Abstractions included discharge or 30-day outcomes (if available) as measured by modified Rankin scale (mRS). Mortality for IS events out to 3 years was determined via all available information including the Social Security Death Index. We compared the outcomes and post-stroke mortality by 20-55 (young stroke) versus >55 years, and by decade. Descriptive statistics are reported as n (%), and mean (SD) or median (25 th and 75 th %ile) as appropriate. The primary analysis examined the effect of age, race and sex using regression, life table and proportional hazards models. Results: Results are shown in the table. IS in the young occurred more frequently among black cases. The median rNIHSS was 3 although the NIHSS distribution trended towards more severe IS in the older age group. Young strokes had lower baseline and 30-day mRS. The mortality rate was greater in the older ages, at each time point and overall. After adjusting for race, sex and stroke severity the hazard ratio for lower survival in the strokes >55 years old was 4.03 (95% CI 3.15, 5.17). Conclusion: IS patients < 55 years old are less likely to die after stroke. Young stroke occurs in demographically different populations than older strokes and this group would benefit from further study.
- 22 January 2018
- Published by Wolters Kluwer Health in Stroke
- Vol. 49  (Suppl_1)
Abstract TMP61: Acute Ischemic Stroke Emergency Department Arrival Times in the Extended Time Window Within a Population
Introduction: With the recent positive clinical trial extending the time window for endovascular therapy out to 24 hours, we sought to describe the arrival times of acute ischemic stroke patients within the 6-24 hour time frame within a large biracial population representative of the US in terms of % black, age, and socioeconomic indicators. Methods: We identified all ischemic stroke (IS) cases by screening all local hospital ICD-9 codes 430-436 among residents of the Greater Cincinnati/Northern Kentucky Stroke Study region, a biracial population of 1.3 million in 2010. Study nurses abstracted relevant information from the medical record, including symptom onset and ED arrival times, and all potential cases were physician reviewed. Arrival time was defined as the elapsed time between symptom onset time (either the witnessed onset time, or time last seen normal) and time of ED arrival. Only cases presenting to an ED were included in this analysis. Student’s t-test and Wilcoxon rank sum tests were used as appropriate. Results: In 2010, there were 1980 IS cases presenting to a local emergency department, who were 21.3% black, 55.1% female, with a median age of 69.4 (SD 14.9). See Figure for distribution of arrival times. Patients arriving > 6 hours were significantly younger (age 68.8 vs. 70.7, p=0.007), more frequently female (56.6% vs. 52.0%, p = 0.05) and had less severe infarcts (NIHSS median (IQR) was 3 (1-6) vs. 4 (1-11), pDiscussion: In our population, inclusion of 6-24hr ED arrival times allows 34% more of our ischemic stroke population to be arriving within a timeframe of possible intervention/reperfusion therapy. Further exploration of eligibility criteria, in addition to time, for extended time-window embolectomy within a population is needed to assist centers as they change their systems of care.
- 22 January 2018
- Published by Wolters Kluwer Health in Stroke
- Vol. 49  (Suppl_1)
Abstract TMP61: Acute Ischemic Stroke Emergency Department Arrival Times in the Extended Time Window Within a Population
Introduction: With the recent positive clinical trial extending the time window for endovascular therapy out to 24 hours, we sought to describe the arrival times of acute ischemic stroke patients within the 6-24 hour time frame within a large biracial population representative of the US in terms of % black, age, and socioeconomic indicators. Methods: We identified all ischemic stroke (IS) cases by screening all local hospital ICD-9 codes 430-436 among residents of the Greater Cincinnati/Northern Kentucky Stroke Study region, a biracial population of 1.3 million in 2010. Study nurses abstracted relevant information from the medical record, including symptom onset and ED arrival times, and all potential cases were physician reviewed. Arrival time was defined as the elapsed time between symptom onset time (either the witnessed onset time, or time last seen normal) and time of ED arrival. Only cases presenting to an ED were included in this analysis. Student’s t-test and Wilcoxon rank sum tests were used as appropriate. Results: In 2010, there were 1980 IS cases presenting to a local emergency department, who were 21.3% black, 55.1% female, with a median age of 69.4 (SD 14.9). See Figure for distribution of arrival times. Patients arriving > 6 hours were significantly younger (age 68.8 vs. 70.7, p=0.007), more frequently female (56.6% vs. 52.0%, p = 0.05) and had less severe infarcts (NIHSS median (IQR) was 3 (1-6) vs. 4 (1-11), pDiscussion: In our population, inclusion of 6-24hr ED arrival times allows 34% more of our ischemic stroke population to be arriving within a timeframe of possible intervention/reperfusion therapy. Further exploration of eligibility criteria, in addition to time, for extended time-window embolectomy within a population is needed to assist centers as they change their systems of care.
- 22 January 2018
- Published by Wolters Kluwer Health in Stroke
- Vol. 49  (Suppl_1)
Abstract WMP91: Post-Stroke Healthcare Utilization: Patterns in Stroke Follow-up Care in a Community Hospital System - A Preliminary Analysis From the Greater Cincinnati/Northern Kentucky Stroke Study
Introduction: Immediate post-stroke discharge destination is easily determined. Long-term disposition and healthcare utilization is more difficult to study due to the variability in outcomes, including multiple transitions for many patients. We sought to longitudinally determine place of residence and physician follow-up in a defined population. Methods: Our population-based stroke epidemiology study retrospectively ascertains hospitalized ischemic and hemorrhagic strokes via ICD-9/10 codes within 5 counties in the greater Cincinnati metropolitan region. For this study, post-stroke dispositions and physician encounters for ischemic strokes that presented to one healthcare system of 4 community hospitals from 1/1/15 to 12/31/15 were analyzed by mining patient electronic medical records (EMRs). Disposition was analyzed at discharge, 3, and 6 months post-stroke, and outpatient and emergency department (ED) visits, and hospital admissions, were tabulated at 3, 6, and 12 months. The first post-discharge physician encounter was also assessed, and time to encounter was considered. Previous analysis has shown that this network is relatively self-contained with few transfers to other health systems, making it ideal for this study. Results: See figure for details. Only 17% of the cohort saw a neurologist within 1 year, whereas 73% saw a primary care provider (PCP) and 37% saw a cardiologist. PCPs accounted for 56% of the first post-stroke encounters. Over 24% of the cohort visited the ED or were re-hospitalized before having their first outpatient visit. Conclusions: In a community setting, PCPs are responsible for the majority of post-stroke care, and fewer than one in five patients sees a neurologist post-stroke. Future work will include additional analysis to determine whether the results from this health system are consistent with others in our region.
- 22 January 2018
- Published by Wolters Kluwer Health in Stroke
- Vol. 49  (Suppl_1)
Abstract WMP91: Post-Stroke Healthcare Utilization: Patterns in Stroke Follow-up Care in a Community Hospital System - A Preliminary Analysis From the Greater Cincinnati/Northern Kentucky Stroke Study
Introduction: Immediate post-stroke discharge destination is easily determined. Long-term disposition and healthcare utilization is more difficult to study due to the variability in outcomes, including multiple transitions for many patients. We sought to longitudinally determine place of residence and physician follow-up in a defined population. Methods: Our population-based stroke epidemiology study retrospectively ascertains hospitalized ischemic and hemorrhagic strokes via ICD-9/10 codes within 5 counties in the greater Cincinnati metropolitan region. For this study, post-stroke dispositions and physician encounters for ischemic strokes that presented to one healthcare system of 4 community hospitals from 1/1/15 to 12/31/15 were analyzed by mining patient electronic medical records (EMRs). Disposition was analyzed at discharge, 3, and 6 months post-stroke, and outpatient and emergency department (ED) visits, and hospital admissions, were tabulated at 3, 6, and 12 months. The first post-discharge physician encounter was also assessed, and time to encounter was considered. Previous analysis has shown that this network is relatively self-contained with few transfers to other health systems, making it ideal for this study. Results: See figure for details. Only 17% of the cohort saw a neurologist within 1 year, whereas 73% saw a primary care provider (PCP) and 37% saw a cardiologist. PCPs accounted for 56% of the first post-stroke encounters. Over 24% of the cohort visited the ED or were re-hospitalized before having their first outpatient visit. Conclusions: In a community setting, PCPs are responsible for the majority of post-stroke care, and fewer than one in five patients sees a neurologist post-stroke. Future work will include additional analysis to determine whether the results from this health system are consistent with others in our region.
- 22 January 2018
- Published by Wolters Kluwer Health in Stroke
- Vol. 49  (Suppl_1)
Abstract WP176: Temporal Trends in Public Awareness of Stroke: Knowledge is Key
Introduction: Recognition of stroke symptoms is vital for accessing medical care and administration of thrombolytics and/or endovascular therapy for ischemic stroke. Awareness of stroke warning signs and risk factors is key to treatment and prevention, respectively. Methods: Surveys were conducted in 1995, 2000, 2005, 2011 and 2016 to respondents randomly drawn to reflect the age, race and sex distribution of the ischemic stroke population in the Greater Cincinnati/ Northern Kentucky Stroke Study. All surveys are based in the same biracial population of 1.3 million, subjects were contacted using random-digit dialing. Open-ended questions regarding stroke risk factors and warning signs were asked and demographic and stroke risk factor information collected. Multiple regression was used to examine changes over time and adjust for covariates. Results: Over the 20-year period, 10,393 surveys were completed. Survey respondents were 60% female, 27% black, with median age 67 years. As depicted in the Table, knowledge of risk factors and warning signs has significantly increased over time, however not within the past 5 years. This is also true after adjustment for age, race, sex and education of the respondents. Female sex and higher education levels were significantly associated with higher knowledge, but age and race had no independent effect. Conclusions: Public awareness of stroke risk factors and warning signs has improved over the past 20 years, although progress has slowed during the past five years despite numerous national and regional stroke awareness campaigns. Knowledge of risk factors continues to be significantly worse than knowledge of warning signs. Further study of the effectiveness of stroke public awareness campaigns are needed.
- 22 January 2018
- Published by Wolters Kluwer Health in Stroke
- Vol. 49  (Suppl_1)
Abstract WP176: Temporal Trends in Public Awareness of Stroke: Knowledge is Key
Introduction: Recognition of stroke symptoms is vital for accessing medical care and administration of thrombolytics and/or endovascular therapy for ischemic stroke. Awareness of stroke warning signs and risk factors is key to treatment and prevention, respectively. Methods: Surveys were conducted in 1995, 2000, 2005, 2011 and 2016 to respondents randomly drawn to reflect the age, race and sex distribution of the ischemic stroke population in the Greater Cincinnati/ Northern Kentucky Stroke Study. All surveys are based in the same biracial population of 1.3 million, subjects were contacted using random-digit dialing. Open-ended questions regarding stroke risk factors and warning signs were asked and demographic and stroke risk factor information collected. Multiple regression was used to examine changes over time and adjust for covariates. Results: Over the 20-year period, 10,393 surveys were completed. Survey respondents were 60% female, 27% black, with median age 67 years. As depicted in the Table, knowledge of risk factors and warning signs has significantly increased over time, however not within the past 5 years. This is also true after adjustment for age, race, sex and education of the respondents. Female sex and higher education levels were significantly associated with higher knowledge, but age and race had no independent effect. Conclusions: Public awareness of stroke risk factors and warning signs has improved over the past 20 years, although progress has slowed during the past five years despite numerous national and regional stroke awareness campaigns. Knowledge of risk factors continues to be significantly worse than knowledge of warning signs. Further study of the effectiveness of stroke public awareness campaigns are needed.
- 22 January 2018
- Published by Wolters Kluwer Health in Stroke
- Vol. 49  (Suppl_1)
Abstract WP50: Potential Impact of Triage Using Non-Contrast Head CT and Stroke Severity on a Regional Stroke System of Care: A Population-Based Study
Background and Purpose: Acute ischemic stroke (AIS) patients may benefit from endovascular therapy (EVT) up to 24 hours since last known normal (LKN). Advanced imaging, including CT or MR angiography and perfusion studies, is required for patient selection. Large non-thrombectomy centers may be able to obtain and interpret these images quickly, but smaller hospitals may not have sufficient real-time CT technician and radiology support. We estimated transfer rates using non-contrast head CT and stroke severity to select patients to be transferred to larger centers for evaluation. Methods: We identified all AIS among residents of the Greater Cincinnati/Northern Kentucky Stroke Study region in 2010 comprising approximately 1.3 million people. Study nurses abstracted relevant information from the medical record, including times of symptom onset, LKN, and ED arrival, and all cases were verified by study physicians. Only cases age ≥18 with baseline mRS 0-2 that presented to an ED were included. Among cases that presented between 6 and 24 hours from LKN, those without evidence of acute infarct on head CT and with initial NIHSS ≥6 or ≥10 were identified. Results: Of 1359 AIS cases at local EDs, 448 (33.0%) presented between 6 and 24 hours, of which s383 (85.5%) showed no evidence of acute infarct on CT. Of cases with no acute infarct on CT, 89/383 (23.2%) had NIHSS ≥6, of which 66 (74.2%) initially presented to a hospital without thrombectomy capabilities; and 51/383 (13.3%) had NIHSS ≥10, of which 40 (78.4%) presented to a non-thrombectomy hospital. Conclusions: From 6 to 24 hours after stroke onset within our population, 40-66 AIS patients annually (0.8-1.3/week, or 3-5 patients per 100,000 persons per year) may present to non-thrombectomy hospitals and need to be transferred using non-contrast CT and stroke severity as screening tools. Such an approach may sufficiently mitigate the impact of delays in treatment on outcomes, without overburdening the referring nor accepting hospitals.
- 22 January 2018
- Published by Wolters Kluwer Health in Stroke
- Vol. 49  (Suppl_1)
Abstract WP50: Potential Impact of Triage Using Non-Contrast Head CT and Stroke Severity on a Regional Stroke System of Care: A Population-Based Study
Background and Purpose: Acute ischemic stroke (AIS) patients may benefit from endovascular therapy (EVT) up to 24 hours since last known normal (LKN). Advanced imaging, including CT or MR angiography and perfusion studies, is required for patient selection. Large non-thrombectomy centers may be able to obtain and interpret these images quickly, but smaller hospitals may not have sufficient real-time CT technician and radiology support. We estimated transfer rates using non-contrast head CT and stroke severity to select patients to be transferred to larger centers for evaluation. Methods: We identified all AIS among residents of the Greater Cincinnati/Northern Kentucky Stroke Study region in 2010 comprising approximately 1.3 million people. Study nurses abstracted relevant information from the medical record, including times of symptom onset, LKN, and ED arrival, and all cases were verified by study physicians. Only cases age ≥18 with baseline mRS 0-2 that presented to an ED were included. Among cases that presented between 6 and 24 hours from LKN, those without evidence of acute infarct on head CT and with initial NIHSS ≥6 or ≥10 were identified. Results: Of 1359 AIS cases at local EDs, 448 (33.0%) presented between 6 and 24 hours, of which s383 (85.5%) showed no evidence of acute infarct on CT. Of cases with no acute infarct on CT, 89/383 (23.2%) had NIHSS ≥6, of which 66 (74.2%) initially presented to a hospital without thrombectomy capabilities; and 51/383 (13.3%) had NIHSS ≥10, of which 40 (78.4%) presented to a non-thrombectomy hospital. Conclusions: From 6 to 24 hours after stroke onset within our population, 40-66 AIS patients annually (0.8-1.3/week, or 3-5 patients per 100,000 persons per year) may present to non-thrombectomy hospitals and need to be transferred using non-contrast CT and stroke severity as screening tools. Such an approach may sufficiently mitigate the impact of delays in treatment on outcomes, without overburdening the referring nor accepting hospitals.
- 22 January 2018
- Published by Wolters Kluwer Health in Stroke
- Vol. 49  (Suppl_1)
Abstract TP181: Prior Antiplatelet Use and Baseline Stroke Severity: A Population-Based Study
Introduction: There is conflicting evidence on the association of antiplatelet (AP) use prior to admission with baseline ischemic stroke (IS) severity. We evaluated this association within a large, bi-racial population. Methods: We identified all hospital-ascertained cases of IS that occurred in 2010 (including ED arriving, direct admits, and in-hospital strokes) within a population of 1.3 million. Specific AP used prior to presentation for IS were aspirin, clopidogrel, dipyridamole, prasugrel, and cilostazol. We excluded those on an anticoagulant (AC) medication for this analysis. Baseline IS severity was defined as NIH stroke scale score (NIHSS) on admission. A multivariable linear regression model including demographic and clinical variables with log-transformed NIHSS as the dependent variable was used to evaluate the effect of prior AP use on stroke severity (results shown as percentage change in NIHSS). Results: In 2010, there were 2259 IS cases, of which 1982 (22% black, 55% female, median age 70 years [58, 81]) were included in the analysis, and 998 (50%) had history of prior AP use. Unadjusted, minor stroke (NIHSS ≤5) was slightly less common in those with prior AP use compared with those without (68% vs. 72%; p=0.04). In the multivariable model among patients with history of atrial fibrillation (AF) yet not on AC, a significant 23% reduction in NIHSS (average NIHSS 6.00 to 4.88, p=0.02) was seen in those with prior AP use. No such association was found in patients with no history of AF. The table displays the multivariable model of stroke severity. Conclusion: We found that prior AP use did not have significant association with baseline stroke severity in the multivariable analysis. However, a subgroup of patients with history of AF had significantly less severe strokes with prior antiplatelet use.
- 22 January 2018
- Published by Wolters Kluwer Health in Stroke
- Vol. 49  (Suppl_1)
Abstract TP181: Prior Antiplatelet Use and Baseline Stroke Severity: A Population-Based Study
Introduction: There is conflicting evidence on the association of antiplatelet (AP) use prior to admission with baseline ischemic stroke (IS) severity. We evaluated this association within a large, bi-racial population. Methods: We identified all hospital-ascertained cases of IS that occurred in 2010 (including ED arriving, direct admits, and in-hospital strokes) within a population of 1.3 million. Specific AP used prior to presentation for IS were aspirin, clopidogrel, dipyridamole, prasugrel, and cilostazol. We excluded those on an anticoagulant (AC) medication for this analysis. Baseline IS severity was defined as NIH stroke scale score (NIHSS) on admission. A multivariable linear regression model including demographic and clinical variables with log-transformed NIHSS as the dependent variable was used to evaluate the effect of prior AP use on stroke severity (results shown as percentage change in NIHSS). Results: In 2010, there were 2259 IS cases, of which 1982 (22% black, 55% female, median age 70 years [58, 81]) were included in the analysis, and 998 (50%) had history of prior AP use. Unadjusted, minor stroke (NIHSS ≤5) was slightly less common in those with prior AP use compared with those without (68% vs. 72%; p=0.04). In the multivariable model among patients with history of atrial fibrillation (AF) yet not on AC, a significant 23% reduction in NIHSS (average NIHSS 6.00 to 4.88, p=0.02) was seen in those with prior AP use. No such association was found in patients with no history of AF. The table displays the multivariable model of stroke severity. Conclusion: We found that prior AP use did not have significant association with baseline stroke severity in the multivariable analysis. However, a subgroup of patients with history of AF had significantly less severe strokes with prior antiplatelet use.
- Open Access
- 29 September 2015
- Published by Springer Nature in Health and Quality of Life Outcomes
- Vol. 13  (1) , 1-9
The negative impact of spasticity on the health-related quality of life of stroke survivors: a longitudinal cohort study
Spasticity often leads to symptomatic and functional problems that can cause disability for stroke survivors. We studied whether spasticity has a negative impact on health-related quality of life (HRQoL). As part of the Greater Cincinnati/Northern Kentucky Stroke Study (NCT00642213), 460 ischemic stroke patients were interviewed during hospitalization and then followed over time. HRQoL was measured by the Physical Component Summary (PCS) and Mental Component Summary (MCS) scores of the Short Form-12 (SF-12), EuroQol-5 dimension (EQ-5D), and Stroke-Specific Quality of Life (SSQOL) instruments, with lower scores indicating worse health. HRQoL differences between stroke survivors with and without spasticity were compared, adjusting for age, race, stroke severity, pre-stroke function, and comorbidities. Of the 460 ischemic stroke patients, 328 had spasticity data available 3 months after their stroke (mean age of 66 years, 49 % were female, and 26 % were black). Of these patients, 54 (16 %) reported having spasticity. Three months following their stroke, patients who reported spasticity had lower mean scores on the PCS (29.6 ± 1.4 vs 37.3 ± 0.6; P < .001), EQ-5D (0.59 ± 0.03 vs 0.71 ± 0.01; P < .001), and SSQOL (3.57 ± 0.08 versus 3.78 ± 0.03; P = .03) compared with patients who did not report spasticity. Lower HRQoL scores were also observed at the 1-year (PCS, EQ-5D, and SSQOL) and 2-year (EQ-5D and SSQOL) interviews in those with spasticity compared with those without spasticity. Statistically and clinically meaningful differences in HRQoL exist between stroke survivors with and without spasticity.
- 29 September 2015
- Published by Springer Nature in Health and Quality of Life Outcomes
- Vol. 13  (1) , 1-9
Open AccessThe negative impact of spasticity on the health-related quality of life of stroke survivors: a longitudinal cohort study
Spasticity often leads to symptomatic and functional problems that can cause disability for stroke survivors. We studied whether spasticity has a negative impact on health-related quality of life (HRQoL). As part of the Greater Cincinnati/Northern Kentucky Stroke Study (NCT00642213), 460 ischemic stroke patients were interviewed during hospitalization and then followed over time. HRQoL was measured by the Physical Component Summary (PCS) and Mental Component Summary (MCS) scores of the Short Form-12 (SF-12), EuroQol-5 dimension (EQ-5D), and Stroke-Specific Quality of Life (SSQOL) instruments, with lower scores indicating worse health. HRQoL differences between stroke survivors with and without spasticity were compared, adjusting for age, race, stroke severity, pre-stroke function, and comorbidities. Of the 460 ischemic stroke patients, 328 had spasticity data available 3 months after their stroke (mean age of 66 years, 49 % were female, and 26 % were black). Of these patients, 54 (16 %) reported having spasticity. Three months following their stroke, patients who reported spasticity had lower mean scores on the PCS (29.6 ± 1.4 vs 37.3 ± 0.6; P < .001), EQ-5D (0.59 ± 0.03 vs 0.71 ± 0.01; P < .001), and SSQOL (3.57 ± 0.08 versus 3.78 ± 0.03; P = .03) compared with patients who did not report spasticity. Lower HRQoL scores were also observed at the 1-year (PCS, EQ-5D, and SSQOL) and 2-year (EQ-5D and SSQOL) interviews in those with spasticity compared with those without spasticity. Statistically and clinically meaningful differences in HRQoL exist between stroke survivors with and without spasticity.
- Open Access
- 25 September 2015
- Published by Springer Nature in BMC Neurology
- Vol. 15  (1) , 1-6
The impact of Magnetic Resonance Imaging (MRI) on ischemic stroke detection and incidence: minimal impact within a population-based study
There are several situations in which magnetic resonance imaging (MRI) might impact whether an cerebrovascular event is considered a new stroke. These include clinically non-focal events with positive imaging for acute cerebral infarction, and worsening of older symptoms without evidence of new infarction on MRI. We sought to investigate the impact of MRI on stroke detection and stroke incidence, by describing agreement between a strictly clinical definition of stroke and a definition based on physician opinion, including MRI imaging findings. All hospitalized strokes that occurred in five Ohio and Northern Kentucky counties (population 1.3 million) in the calendar year of 2005 were identified using ICD-9 discharge codes 430–436. The two definitions used were: “clinical case definition” which included sudden onset focal neurologic symptoms referable to a vascular territory for >24 h, compared to the “best clinical judgment of the physician definition”, which considers all relevant information, including neuroimaging findings. The 95 % confidence intervals (CI) for the incidence rates were calculated assuming a Poisson distribution. Rates were standardized to the 2000 U.S. population, adjusting for age, race, and sex, and included all age groups. There were 2403 ischemic stroke events in 2269 patients; 1556 (64 %) had MRI performed. Of the events, 2049 (83 %) were cases by both definitions, 185 (7.7 %) met the clinical case definition but were non-cases in the physician’s opinion and 169 (7.0 %) were non-cases by clinical definition but were cases in the physician’s opinion. There was no significant difference in the incidence rates of first-ever or total ischemic strokes generated by the two different definitions, or when only those with MRI imaging were included. We found that MRI findings do not appear to substantially change stroke incidence estimates, as the strictly clinical definition of stroke did not significantly differ from a definition that included imaging findings. Including MRI in the case definition “rules out” almost the same number of strokes as it “rules in”.
- 25 September 2015
- Published by Springer Nature in BMC Neurology
- Vol. 15  (1) , 1-6
Open AccessThe impact of Magnetic Resonance Imaging (MRI) on ischemic stroke detection and incidence: minimal impact within a population-based study
There are several situations in which magnetic resonance imaging (MRI) might impact whether an cerebrovascular event is considered a new stroke. These include clinically non-focal events with positive imaging for acute cerebral infarction, and worsening of older symptoms without evidence of new infarction on MRI. We sought to investigate the impact of MRI on stroke detection and stroke incidence, by describing agreement between a strictly clinical definition of stroke and a definition based on physician opinion, including MRI imaging findings. All hospitalized strokes that occurred in five Ohio and Northern Kentucky counties (population 1.3 million) in the calendar year of 2005 were identified using ICD-9 discharge codes 430–436. The two definitions used were: “clinical case definition” which included sudden onset focal neurologic symptoms referable to a vascular territory for >24 h, compared to the “best clinical judgment of the physician definition”, which considers all relevant information, including neuroimaging findings. The 95 % confidence intervals (CI) for the incidence rates were calculated assuming a Poisson distribution. Rates were standardized to the 2000 U.S. population, adjusting for age, race, and sex, and included all age groups. There were 2403 ischemic stroke events in 2269 patients; 1556 (64 %) had MRI performed. Of the events, 2049 (83 %) were cases by both definitions, 185 (7.7 %) met the clinical case definition but were non-cases in the physician’s opinion and 169 (7.0 %) were non-cases by clinical definition but were cases in the physician’s opinion. There was no significant difference in the incidence rates of first-ever or total ischemic strokes generated by the two different definitions, or when only those with MRI imaging were included. We found that MRI findings do not appear to substantially change stroke incidence estimates, as the strictly clinical definition of stroke did not significantly differ from a definition that included imaging findings. Including MRI in the case definition “rules out” almost the same number of strokes as it “rules in”.
- 1 August 2012
- Published by Wolters Kluwer Health in Stroke
- Vol. 43  (8) , 2055-2059
Patients Living in Impoverished Areas Have More Severe Ischemic Strokes
Background and Purpose—: Initial stroke severity is one of the strongest predictors of eventual stroke outcome. However, predictors of initial stroke severity have not been well-described within a population. We hypothesized that poorer patients would have a higher initial stroke severity on presentation to medical attention. Methods—: We identified all cases of hospital-ascertained ischemic stroke occurring in 2005 within a biracial population of 1.3 million. “Community” socioecomic status was determined for each patient based on the percentage below poverty in the census tract in which the patient resided. Linear regression was used to model the effect of socioeconomic status on stroke severity. Models were adjusted for race, gender, age, prestroke disability, and history of medical comorbidities. Results—: There were 1895 ischemic stroke events detected in 2005 included in this analysis; 22% were black, 52% were female, and the mean age was 71 years (range, 19–104). The median National Institutes of Health Stroke Scale was 3 (range, 0–40). The poorest community socioeconomic status was associated with a significantly increased initial National Institutes of Health Stroke Scale by 1.5 points (95% confidence interval, 0.5–2.6; P <0.001) compared with the richest category in the univariate analysis, which increased to 2.2 points after adjustment for demographics and comorbidities. Conclusions—: We found that increasing community poverty was associated with worse stroke severity at presentation, independent of other known factors associated with stroke outcomes. Socioeconomic status may impact stroke severity via medication compliance, access to care, and cultural factors, or may be a proxy measure for undiagnosed disease states.
- 1 August 2012
- Published by Wolters Kluwer Health in Stroke
- Vol. 43  (8) , 2055-2059
Patients Living in Impoverished Areas Have More Severe Ischemic Strokes
Background and Purpose—: Initial stroke severity is one of the strongest predictors of eventual stroke outcome. However, predictors of initial stroke severity have not been well-described within a population. We hypothesized that poorer patients would have a higher initial stroke severity on presentation to medical attention. Methods—: We identified all cases of hospital-ascertained ischemic stroke occurring in 2005 within a biracial population of 1.3 million. “Community” socioecomic status was determined for each patient based on the percentage below poverty in the census tract in which the patient resided. Linear regression was used to model the effect of socioeconomic status on stroke severity. Models were adjusted for race, gender, age, prestroke disability, and history of medical comorbidities. Results—: There were 1895 ischemic stroke events detected in 2005 included in this analysis; 22% were black, 52% were female, and the mean age was 71 years (range, 19–104). The median National Institutes of Health Stroke Scale was 3 (range, 0–40). The poorest community socioeconomic status was associated with a significantly increased initial National Institutes of Health Stroke Scale by 1.5 points (95% confidence interval, 0.5–2.6; P <0.001) compared with the richest category in the univariate analysis, which increased to 2.2 points after adjustment for demographics and comorbidities. Conclusions—: We found that increasing community poverty was associated with worse stroke severity at presentation, independent of other known factors associated with stroke outcomes. Socioeconomic status may impact stroke severity via medication compliance, access to care, and cultural factors, or may be a proxy measure for undiagnosed disease states.